Estimates suggest that the anti-counterfeit pharmaceutical packaging market will be worth US$ 108.1 billion by 2023. Projections indicate a substantial growth trajectory, with the market poised to soar to US$ 246.6 billion by 2033, boasting an impressive compound annual growth rate (CAGR) of 8.6%. This growth is attributed to the escalating need for enhanced security measures in the pharmaceutical industry to combat counterfeit drugs and ensure patient safety. As regulatory scrutiny intensifies and technological advancements continue to evolve, the demand for innovative anti-counterfeit packaging solutions is expected to surge, driving market expansion over the next decade.
The increasing emergence of new anti-counterfeiting technologies, such as edible micro tags can only be scanned through the utilization of the manufacturer’s proprietary equipment. It is also helping expand the global anti-counterfeit pharmaceutical packaging market.
Germany’s position as a leader in innovation and technology plays a pivotal role in the expected growth of the anti-counterfeit pharmaceutical packaging industry. With a projected market value of US$ 148.6 billion in 2023, Germany’s pharmaceutical packaging sector is set to thrive. This growth is primarily attributed to the nation’s robust commitment to technological advancements and its reputation for pioneering cutting-edge solutions.
Request Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-2385
The increasing prevalence of counterfeit pharmaceuticals poses a significant threat to public health. As awareness of this issue grows, pharmaceutical companies and regulatory bodies are taking strong measures to combat counterfeiting. It is done through advanced packaging solutions, which in turn drives the demand for anti-counterfeit pharmaceutical packaging.
Continuous advancements in anti-counterfeit technologies have made it feasible and cost-effective for pharmaceutical companies to implement robust security measures. Increasing strict regulation by governments and regulatory agencies for pharmaceutical packaging is likely to drive the market throughout the forecast period.
The growth of online pharmaceutical sales and e-commerce platforms has made it easy for counterfeit drugs to enter the market. E-commerce platforms are adopting anti-counterfeit packaging to protect consumers. The pharmaceutical industry’s continued growth and expansion into emerging markets are driving the need for anti-counterfeit measures.
Key Takeaways
- From 2018 to 2022, the anti-counterfeit pharmaceutical packaging market demand expanded at a CAGR of 6%
- Based on printing technology, the RFID segment is expected to account for a market share of 7.8% during the forecast period.
- Global anti-counterfeit pharmaceutical packaging demand in the United Kingdom is predicted to account for a CAGR of 8.4% through 2033.
- In the United States, the market is expected to account for a CAGR of 8.5% between 2023 and 2033.
- China is projected to expand by a value CAGR of 8.3% through 2033.
- By 2033, India’s anti-counterfeit pharmaceutical packaging market is anticipated to record a CAGR of 8.0%.
“The increasing consumer awareness and expansion of the pharmaceutical industry globally is anticipated to drive the market growth during the forecast period.” says an FMI analyst.
Business Growth Drivers:
- Stringent Regulations: Increasing regulatory requirements and government initiatives aimed at combating counterfeit drugs have been a major driver. Regulatory bodies worldwide have mandated the implementation of anti-counterfeit measures to ensure patient safety and maintain the integrity of pharmaceutical products.
- Rising Incidences of Counterfeiting: With the growth of the pharmaceutical industry, the incidents of counterfeit drugs entering the market have also risen. This has propelled pharmaceutical companies to invest in robust anti-counterfeit packaging solutions to protect their products and brand reputation.
- Technological Advancements: Advances in anti-counterfeit technologies such as RFID (Radio Frequency Identification), barcoding, holograms, tamper-evident seals, and track-and-trace systems have made it easier for pharmaceutical companies to implement effective anti-counterfeit measures.
- Increasing Awareness: Growing awareness among consumers regarding the dangers associated with counterfeit drugs has driven the demand for secure packaging solutions. Patients are increasingly demanding assurances about the authenticity and safety of the medicines they consume, pushing pharmaceutical companies to invest in anti-counterfeit measures.
- Globalization of Pharmaceutical Supply Chains: The globalization of pharmaceutical supply chains has made them more vulnerable to counterfeiting. This has led to the adoption of comprehensive anti-counterfeit strategies to safeguard products throughout the supply chain, from manufacturing to distribution.
Industry Restraints:
- Cost of Implementation: One of the primary restraints is the cost associated with implementing anti-counterfeit measures. Pharmaceutical companies may find it challenging to justify the initial investment required for deploying sophisticated anti-counterfeit technologies, especially for smaller or generic drug manufacturers.
- Complexity and Integration Challenges: Integrating anti-counterfeit technologies into existing packaging processes can be complex and time-consuming. Pharmaceutical companies may face technical challenges in seamlessly integrating these solutions into their production lines without disrupting operations.
- Resistance to Change: Resistance to change within the industry can hinder the adoption of anti-counterfeit technologies. Some companies may be hesitant to invest in new technologies or upgrade existing systems due to concerns about disruptions, compatibility issues, or reluctance to depart from traditional packaging methods.
- Counterfeiters’ Innovation: Despite advancements in anti-counterfeit technologies, counterfeiters are also continually innovating their methods to bypass security measures. This ongoing cat-and-mouse game presents a challenge for pharmaceutical companies in staying ahead of counterfeiters and maintaining the efficacy of their anti-counterfeit strategies.
- Global Variability in Regulations: Regulatory requirements for anti-counterfeit measures vary across different regions and countries, leading to compliance challenges for multinational pharmaceutical companies. Navigating the complex regulatory landscape and ensuring compliance with diverse standards can be a significant restraint for companies operating in multiple markets.
Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-2385
Competitive Landscape
Leading anti-counterfeit pharmaceutical packaging manufacturers increasingly focus on expanding their product offerings to strengthen their customer base. They are adopting growth strategies such as new product launches, partnerships, acquisitions, mergers, collaborations, etc. They expand their global footprint and gain a competitive edge in the market by following these strategies.
Some pharma companies have set up departments whose primary function is safeguarding their brand name from counterfeiting and illicit replication, raising the demand for anti-counterfeit pharmaceutical packaging.
- IBM has been exploring the use of blockchain technology in pharmaceutical supply chains. They have collaborated with various pharmaceutical companies and regulatory bodies to create transparent and secure systems for tracking the provenance of pharmaceutical products
- Systech offers serialization and traceability solutions for pharmaceutical companies. Their platform helps pharmaceutical manufacturers comply with track-and-trace regulations and provides real-time visibility into the supply chain.
- Optel Group provides traceability and serialization solutions for the pharmaceutical industry. They have actively implemented track-and-trace systems to prevent counterfeit drugs from entering the supply chain.
Some of the key players in the global anti-counterfeit pharmaceutical packaging market are
- Alien Technology
- ATL Security Label Systems
- CCL Industries
- SICPA Holdings
- Schott AG
- Gerresheimer AG
- Klockner Pentaplast Group
- Ardagh Group S.A.
- Nipro Corporation
- Authentix Inc.
- TruTag Technologies Inc.
- Zebra Technologies Corporation
- Alpvision SA
- OpSec Security Inc.
- Savi Technology Inc.
- 3M
- Stevanato Group.
Buy Now/Purchase: https://www.futuremarketinsights.com/checkout/2385
Key Segmentations:
By Packaging Format :
- Bottles & Jars
- Vials & Ampoules
- Blisters
- Trays
- Pouches & Sachets
- Others (Tubes, Syringes, etc.)
By Printing Technology :
- RFID
- Security Inks & Coatings
- Security Seals
- Holograms
- Mass Encryption
- Barcode
- Mass Serialization
By Adhesion :
- Permanent
- Removable
- Repositionable
By End-application :
- Pharma & Biological
- Medical & Supplies
- Gloves
- Scissors
- Syringes & Needles
- Surgical Tapes
- Others
- Medical Equipment
- Surgical
- Therapeutic
- Diagnostic
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube